关注
SSuryani M.Sc
SSuryani M.Sc
Insitut Pertanian Bogor
在 apps.ipb.ac.id 的电子邮件经过验证
标题
引用次数
引用次数
年份
B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans
DT Avery, EK Deenick, CS Ma, S Suryani, N Simpson, GY Chew, ...
Journal of Experimental Medicine 207 (1), 155-171, 2010
4522010
Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL‐12
CS Ma, S Suryani, DT Avery, A Chan, R Nanan, B Santner‐Nanan, ...
Immunology and cell biology 87 (8), 590-600, 2009
4052009
Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells
S Suryani, DA Fulcher, B Santner-Nanan, R Nanan, M Wong, PJ Shaw, ...
Blood, The Journal of the American Society of Hematology 115 (3), 519-529, 2010
1742010
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
SL Khaw, S Suryani, K Evans, J Richmond, A Robbins, RT Kurmasheva, ...
Blood, The Journal of the American Society of Hematology 128 (10), 1382-1395, 2016
1712016
Advanced UV examination of wastewater
O Thomas, F Theraulaz, C Agnel, S Suryani
Environmental technology 17 (3), 251-261, 1996
1171996
An interferon-γ-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis
S Suryani, I Sutton
Journal of neuroimmunology 183 (1-2), 96-103, 2007
1162007
In situ TEM and SEM studies on the antimicrobial activity and prevention of Candida albicans biofilm by Cassia spectabilis extract
S Sangetha, Z Zuraini, S Suryani, S Sasidharan
Micron 40 (4), 439-443, 2009
1002009
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling
S Goossens, E Radaelli, O Blanchet, K Durinck, J Van der Meulen, ...
Nature communications 6 (1), 5794, 2015
942015
Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts
S Suryani, H Carol, TN Chonghaile, V Frismantas, C Sarmah, L High, ...
Clinical cancer research 20 (17), 4520-4531, 2014
802014
Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome
ST Cliffe, DB Bloch, S Suryani, EJ Kamsteeg, DT Avery, U Palendira, ...
Journal of allergy and clinical immunology 130 (3), 735-742. e6, 2012
632012
Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia
S Suryani, LS Bracken, RC Harvey, KCS Sia, H Carol, IM Chen, K Evans, ...
Molecular cancer therapeutics 14 (2), 364-374, 2015
622015
Antimicrobial activities and toxicity of crude extract of the Psophocarpus tetragonolobus pods
LY Latha, S Sasidharan, Z Zuraini, S Suryani, L Shirley, S Sangetha, ...
African Journal of Traditional, Complementary and Alternative Medicines 4 (1 …, 2007
462007
Fungicidal effect and oral acute toxicity of Cassia spectabilis leaf extract
S Sangetha, Z Zuraini, S Sasidharan, S Suryani
Nippon Ishinkin Gakkai Zasshi 49 (4), 299-304, 2008
372008
Antimicrobial activities of Cassia surattensis and Cassia fistula
SN Sangetha, Z Zuraini, S Sasidharan, S Suryani
J Mol Biol Biotech 1 (1), 1-4, 2008
342008
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation
Y Huang, JAI Thoms, ML Tursky, K Knezevic, D Beck, V Chandrakanthan, ...
Leukemia 30 (7), 1552-1561, 2016
272016
Therapeutic implications of advances in our understanding of transitional B-cell development in humans
S Suryani, SG Tangye
Expert Review of Clinical Immunology 6 (5), 765-775, 2010
122010
Venetoclax responses of pediatric ALL xenografts reveal MLLr ALL sensitivity, but overall requirement to target both BCL2 and BCLXL
SL Khaw, S Suryani, K Evans, J Richmond, A Robbins, RT Kurmasheva, ...
Blood 128 (10), 1382-1395, 2016
82016
Evaluation of the Bcl-2 inhibitor ABT-199 in xenograft models of acute lymphoblastic leukemia by the pediatric preclinical testing program
S Suryani, K Evans, J Richmond, A Robbins, L Bracken, R Kurmasheva, ...
Cancer Research 75 (15_Supplement), 3276-3276, 2015
42015
Bioethanol Production by Using Detoxified Sugarcane Bagasse Hydrolysate and Adapted Culture of Candida tropicalis
I Setyawati, L Ambarsari, S Nur'aeni, S Suryani, PJ Puspita, PA Kurniatin, ...
Current Biochemistry 2 (1), 1-12, 2015
42015
The Addition Effects of Glucose as a Co-substrate on Xylitol Production by Candida guilliermondii
L Ambarsari, S Suryani, S Gozales, PJ Puspita
Current Biochemistry 2 (1), 13-21, 2015
22015
系统目前无法执行此操作,请稍后再试。
文章 1–20